Skip to NavigationSkip to content

Top Ten most popular articles on Pharmafile.com this week

Published on 16/10/20 at 10:25am

The top ten news stories this week focus on herd immunity, as the Director of the World Health Organization has warned against pursuing a strategy of herd immunity to fight national COVID-19 outbreaks, while a group of 80 researchers have lent their signatures to an open letter published in the The Lancet warning in particular against the resurgence of the pursuit of herd immunity as a credible strategy to combat national outbreaks of the novel coronavirus.

In other news, Eli Lilly has stopped enrolling volunteers in clinical trials of its antibody treatment for the novel coronavirus over safety concerns, and an American man has caught coronavirus for the second time, with the second infection being far more dangerous than the first.

1. Eli Lilly COVID-19 antibody therapy trial paused over safety concerns

Eli Lilly has stopped enrolling volunteers in clinical trials of its antibody treatment for the novel coronavirus over safety concerns.

2. Head of WHO says herd immunity strategies for COVID-19 are ‘unethical’

Tedros Adhanom Ghebreyesus, Director of the World Health Organization, has warned against pursuing a strategy of herd immunity to fight national COVID-19 outbreaks.

3. Sun Pharma issues recall of its generic diabetes drug in US market

Sun Pharma is recalling 747 bottles of its generic diabetes drug Riomet ER in the US.

4. 80 researchers argue COVID-19 herd immunity strategy is a "dangerous fallacy" in open letter

A group of 80 researchers have lent their signatures to an open letter published in the The Lancet under the title ‘Scientific consensus on the COVID-19 pandemic: We need to act now’, warning in particular against the resurgence of the pursuit of herd immunity as a credible strategy to combat national outbreaks of the novel coronavirus.

5. University of Glasgow research details promising precision medicine approach in pancreatic cancer

Researchers at the University of Glasgow have unveiled a new precision medicine approach to identify and pair pancreatic cancer patients with the therapies most likely to prove effective in repairing DNA damage in their tumour cells.

6. Man in US contracts COVID-19 for the second time with worse symptoms

An American man has caught coronavirus for the second time, with the second infection being far more dangerous than the first.

7. Pharmaceutical industry donating more to Democrats than Republicans in the lead up to 2020 election

The long-term trend of the pharmaceutical industry largely donating to the US Republican Party has been reversed in the lead up to the 2020 election.

8. Scottish Medicines Consortium approves Revlimid for two groups of blood cancer patients

The Scottish Medicines Consortium (SMC) has accepted Revlimid (lenalidomide) for routine use on NHS Scotland for patients with multiple myeloma and follicular lymphoma.

9. British man suffers from permanent hearing damage after contracting COVID-19

A 45-year-old man in the UK has been left with permanent hearing damage after being infected with the novel coronavirus, it has emerged. 

10. J&J halts COVID-19 vaccine study following unidentified participant illness

Johnson & Johnson has announced its decision to slam the brakes on the development programme for its COVID-19 vaccine following the illness of one of the participants.

Conor Kavanagh

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches